Tech Company Financing Transactions
Spitfire Pharma Funding Round
Spitfire Pharma closed a $500 thousand investment round on 3/31/2013. Investors included Presidio Partners.
Transaction Overview
Company Name
Announced On
3/31/2013
Transaction Type
Venture Equity
Amount
$500,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
400 Oyster Point Blvd. 202
South San Francisco, CA 94080
USA
South San Francisco, CA 94080
USA
Phone
Email Address
Not Recorded
Overview
The company is developing a new peptide drug candidate.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Browse more venture capital transactions:
Prev: 3/31/2013: Annovation BioPharma venture capital transaction
Next: 3/31/2013: WikiCell Designs venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC transactions reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs